Reporting Adverse Events or Safety Concerns If you experience or suspect an adverse event, contamination, or quality issue with this product, report it immediately to: Hospira Pfizer: Manufacturer contact information available on the product vial FDA MedWatch: 1-888-SAFEMED (1-888-723-3633) or online at fda.gov/medwatch Poison Control: 1-800-222-1222 (for toxicology guidance) Your institutional pharmacovigilance system: If you work for a hospital, clinic, or healthcare institution Regulatory Compliance By purchasing and using this product, you agree to comply with all applicable FDA regulations, state pharmacy laws, and professional licensing requirements
Using it for weight-loss purposes constitutes off-label use that differs from the approved indication
Los medicamentos GLP-1 disponibles en Estados Unidos incluyen semaglutida inyectable (Ozempic, Wegovy), semaglutida oral (Rybelsus), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda), exenatida (Bydureon BCise) y tirzepatida (Mounjaro, Zepbound)
However, direct experimental evidence showing that selective alteration of mitochondrial positioning or signaling specifically at ZG-rich domains is sufficient to trigger premature trypsinogen activation remains lacking
Thyrotropin, hyperthyroidism, and bone mass
